PPIs are heartburn drugs that have been on the market since the 1980s, as Beasley Allen has previously explained. Read more
Navan Ward is one of five attorneys appointed to the PEC. Read more
PPIs are indicated for the short-term treatment of gastrointestinal reflux disease and gastric ulcers. Read more
A multidistrict Litigation (MDL) transfers all cases pending in federal court to a single venue for consolidated pre-trial discovery. Read more
Lawyers in our Mass Torts Section have been very busy. Read more
15 lawsuits have been filed in federal courts alleging that commonly-used heartburn medications called proton pump inhibitors caused Plaintiffs to develop kidney disease. Read more
Commonly used heartburn medications, otherwise known as proton pump inhibitors (PPIs), are linked to an increased risk for kidney failure and kidney disease. Introduced in the late 1980s for... Read more
AstraZeneca, facing declining revenues last year, sold the marketing rights to its over-the-counter (OTC) version of Nexium to Pfizer Inc. for $250 million. AstraZeneca will be in line for m... Read more
The FDA has warned that taking certain drugs to treat symptoms of heartburn, acid reflux or ulcers may increase the risk of hip, wrist and spine fractures. The drugs belong to a class of med... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.